Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05120908 · ClinicalTrials.gov registry record

Discrimination and the Brain-Gut-Microbiome (BGM) Axis

A clinical trial, sponsored by University of California, Los Angeles.

Completed
Registry status
266
Enrollment target

NCT05120908: Completed study, sponsored by University of California, Los Angeles.

NCT05120908 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 266 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05120908 has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
266 participants
Enrollment target

Study Summary

Obesity is a major public health problem related to a variety of illnesses such as heart disease and diabetes. Prior research indicates that social stressors contribute to risk for obesity, possibly through alterations in diet and physical activity. However, it is not fully clear how these alterations contribute to obesity. The purpose of this study is to examine how the stressors of social isolation and discrimination relate to eating behaviors and dietary patterns, and further, how these behaviors affect the brain-gut-microbiome (BGM) connections. This study will focus on Mexican and Filipina women because research shows that they encounter a high burden of obesity and exposure to social stressors. Approximately 300 Mexican and Filipina women will be screened and enrolled. They will then provide information about social stressors via food diaries, physical body measures (e.g. waist circumference), questionnaire data regarding diet and eating behaviors, and measures of physical activity. Stool and serum will be collected to analyze microbes and metabolomics, and MRI to assess brain changes in the reward network. Analytic techniques will be used to integrate data from these multiple data sources. This analysis will determine the unique differences associated with ethnicity and social stressors in moderating eating behaviors and dietary patterns. The results of this study will provide new information about a possible pathway whereby social stressors affect behavioral, neurological and microbiome mechanisms related to obesity risk and provide new information in BGM patterns in two understudied ethnic groups. In the long term, this research may suggest possible approaches for intervention that may help reduce inequalities in obesity and related health problems.

Primary Outcome

Neuroimaging of participants brain via MRI procedure.

Trial Details

FieldValue
Enrollment Target 266 participants
Start Date 2021-08-24
Est. Completion 2024-12-31

What the finished NCT05120908 record still lists

NCT05120908 is an observational study that tracks outcomes without assigning an intervention. The registered 266 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT05120908 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05120908 about?

NCT05120908 is a clinical study titled "Discrimination and the Brain-Gut-Microbiome (BGM) Axis". Obesity is a major public health problem related to a variety of illnesses such as heart disease and diabetes. Prior research indicates that social stressors contribute to risk for obesity, possibly through alterations in diet and physical activity. However, it is not fully clear how these alteratio...

What is the current status of trial NCT05120908?

This trial is currently completed. The enrollment target is 266 participants. The study started on 2021-08-24. Estimated completion is 2024-12-31.

Who is sponsoring clinical trial NCT05120908?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05098652 · 266 participants · NA

    Coaching Dementia Caregivers to Master Care-Resistant Behavior

  • NCT06088277 · 266 participants · NA

    Texting to Reduce Human Immunodeficiency Virus (HIV) Risk

  • NCT06261814 · 266 participants · Phase 2

    Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors

  • NCT06312124 · 266 participants · NA

    A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05120908, the US trial registry maintained by the National Library of Medicine. NCT05120908 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.